Previous close | 89.04 |
Open | 90.92 |
Bid | 90.60 x N/A |
Ask | 91.22 x N/A |
Day's range | 90.92 - 90.92 |
52-week range | 57.10 - 90.92 |
Volume | |
Avg. volume | 4 |
Market cap | 23.426B |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | N/A |
EPS (TTM) | -9.05 |
Earnings date | 05 Aug 2024 - 09 Aug 2024 |
Forward dividend & yield | 1.50 (1.68%) |
Ex-dividend date | 21 Jun 2024 |
1y target est | N/A |
IFF (NYSE: IFF), a global leader in food and beverage, home and personal care and health, today announced a new controlled release platform for its portfolio of controlled release products including METHOCEL™, ETHOCEL™, and POLYOX™. Under the banner, "Timing is Everything," the platform provides comprehensive solutions for pharmaceutical therapies to benefit patients and highlights the importance of controlled release of active ingredients and improving patient compliance. Complete with educatio
Insight into Dodge & Cox (Trades, Portfolio)'s First Quarter 2024 Investment Moves and Strategic Decisions
Examine the evolution of International Flavors' (IFF) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.